# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst Richard Newitter maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $102 t...
Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $105 to $85.
Goldman Sachs analyst Kate McShane maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $104 to $89.
Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps m...
Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ: DXCM) with a Buy and maintains $106 price target.
10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opin...
Baird analyst Jeff Johnson maintains DexCom (NASDAQ: DXCM) with a Outperform and lowers the price target from $112 to $90.